{
  "basic_data": [
    {
      "cell_line_alt_name": "RYR1-4833-87",
      "cell_type": "iPSC",
      "frozen": "True",
      "hpscreg_name": "HPIi008-A"
    }
  ],
  "generator": [
    {
      "group": "Harry Perkins Institute of Medical Research"
    }
  ],
  "contact": [
    {
      "first_name": "Joshua",
      "name_initials": "S",
      "e_mail": "joshua.clayton@perkins.org.au",
      "last_name": "Clayton",
      "group": "Harry Perkins Institute of Medical Research"
    }
  ],
  "publications": [
    {
      "last_author": "Rhonda L. Taylor",
      "year": "2024.0",
      "first_author": "Joshua S. Clayton",
      "doi": "10.1016/j.scr.2024.103411",
      "journal": "Stem Cell Research",
      "title": "Generation of two iPSC lines from adult central core disease patients with dominant missense variants in the RYR1 gene"
    }
  ],
  "donor": [
    {
      "sex": "Female",
      "age": "A25_29",
      "disease_description": "CCD is a congenital myopathy typically diagnosed by the presence of central-typed cores in type I myofibres. Common clinical features include muscle weakness and hypotonia presenting during infancy, delayed motor development, and joint contractures.",
      "disease_name": "Central core disease"
    }
  ],
  "genomic_modifications": [
    {
      "description": "Heterozygous for RYR1 c.14437C>T variant (p.His4813Tyr)",
      "loci_name": "RYR1",
      "cytoband": "19q13.2",
      "genotype": "Heterozygous RYR1:c.14437C>T (p.His4813Tyr)",
      "mutation_type": "VA"
    }
  ],
  "differentiation_results": [
    {
      "description": "In vitro directed differentiation",
      "show_potency": "True",
      "cell_type": "EC",
      "marker_list": "OTX2; PAX6",
      "method_used": "RT-qPCR"
    },
    {
      "description": "In vitro directed differentiation",
      "show_potency": "True",
      "cell_type": "ME",
      "marker_list": "TBXT; BMP4",
      "method_used": "RT-qPCR"
    },
    {
      "description": "In vitro directed differentiation",
      "show_potency": "True",
      "cell_type": "EN",
      "marker_list": "SOX17; GATA4",
      "method_used": "RT-qPCR"
    }
  ],
  "genomic_characterisation": [
    {
      "passage_number": "16",
      "karyotype": "46,XX",
      "summary": "Normal female karyotype for HPIi008-A at passage 16; 15 metaphase counted, 5 analyzed for each.",
      "karyotype_method": "G-banding"
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_origin_term": "blood",
      "derivation_year": "2022",
      "non_int_vector_name": "CytoTune 2.0 Sendai Virus Kit (ThermoFisher Scientific)",
      "i_source_cell_type_term": "EBV-immortalized lymphoblastoid cell (LCL)",
      "non_int_vector": "Sendai virus"
    }
  ],
  "ethics": [
    {
      "institutional_HREC": "University of Western Australia Human Research Ethics Committee",
      "ethics_number": "RA/4/20/1008"
    }
  ],
  "culture_medium": [
    {
      "co2_concentration": "0.05",
      "o2_concentration": "0.21",
      "passage_method": "EN"
    }
  ]
}